Literature DB >> 20853064

Systems-level analysis of gene expression data revealed NR0B2/SHP as potential tumor suppressor in human liver cancer.

Yun-Yong Park1, Hueng-Sik Choi, Ju-Seog Lee.   

Abstract

Nuclear receptors (NRs) play pivotal roles in cell growth, proliferation, differentiation and homeostasis. Recent progress demonstrates that NR is tightly linked to human disease such as cancer, diabetes and obesity. Here we explore NR expression profiles in human tissue using systematic approaches. NR gene profiles reveal that individual NR has its own gene expression signature depending on tissue type. Of many organs, NRs expression is enriched in liver. Expression of many NRs was significantly changed in liver cancer. Notably, NR0B2/SHP expression level was significantly decreased in human liver cancer but not in normal liver. In addition, expression of SHP is well associated with good prognosis. SHP gene network analysis based on microarray data in liver cancer shows that SHP regulates cell proliferation and metabolism related gene sets. Our systematic approaches suggest that loss of SHP expression in liver might be key genetic events during hepatocarcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20853064     DOI: 10.1007/s10059-010-0136-6

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  13 in total

1.  Loss of Hepatic Small Heterodimer Partner Elevates Ileal Bile Acids and Alters Cell Cycle-related Genes in Male Mice.

Authors:  Ryan Philip Henry Shaw; Peter Kolyvas; Nathanlown Dang; Angela Hyon; Keith Bailey; Sayeepriyadarshini Anakk
Journal:  Endocrinology       Date:  2022-06-01       Impact factor: 5.051

2.  An autoregulatory feedback loop between Mdm2 and SHP that fine tunes Mdm2 and SHP stability.

Authors:  Zhihong Yang; Li Wang
Journal:  FEBS Lett       Date:  2012-03-23       Impact factor: 4.124

3.  Loss of the orphan nuclear receptor SHP is more pronounced in fibrolamellar carcinoma than in typical hepatocellular carcinoma.

Authors:  Ewa Wilczek; Grzegorz Szparecki; Dominika Lukasik; Lukasz Koperski; Magdalena Winiarska; Grzegorz M Wilczynski; Aleksander Wasiutynski; Barbara Gornicka
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240

4.  Sensitivity and dose dependency of radiation-induced injury in hematopoietic stem/progenitor cells in mice.

Authors:  Chang-Ying Guo; Lan Luo; Yoshishige Urata; Shinji Goto; Wen-Jing Huang; Syu Takamura; Fumiko Hayashi; Hanako Doi; Yuriko Kitajima; Yusuke Ono; Tomoo Ogi; Tao-Sheng Li
Journal:  Sci Rep       Date:  2015-01-27       Impact factor: 4.379

5.  The Orphan Nuclear Receptor Gene NR0B2 Is a Favorite Prognosis Factor Modulated by Multiple Cellular Signal Pathways in Human Liver Cancers.

Authors:  Runzhi Zhu; Yanjie Tu; Jingxia Chang; Haixia Xu; Jean C Li; Wang Liu; Ahn-Dao Do; Yuxia Zhang; Jinhu Wang; Benyi Li
Journal:  Front Oncol       Date:  2021-05-14       Impact factor: 6.244

6.  A pleiotropic role for the orphan nuclear receptor small heterodimer partner in lipid homeostasis and metabolic pathways.

Authors:  Gabriella Garruti; Helen H Wang; Leonilde Bonfrate; Ornella de Bari; David Q-H Wang; Piero Portincasa
Journal:  J Lipids       Date:  2012-04-22

7.  Zinc-induced Dnmt1 expression involves antagonism between MTF-1 and nuclear receptor SHP.

Authors:  Yuxia Zhang; Glen K Andrews; Li Wang
Journal:  Nucleic Acids Res       Date:  2012-02-22       Impact factor: 16.971

8.  Nuclear receptor small heterodimer partner in apoptosis signaling and liver cancer.

Authors:  Yuxia Zhang; Li Wang
Journal:  Cancers (Basel)       Date:  2011-01-05       Impact factor: 6.639

9.  A hybrid computational method for the discovery of novel reproduction-related genes.

Authors:  Lei Chen; Chen Chu; Xiangyin Kong; Guohua Huang; Tao Huang; Yu-Dong Cai
Journal:  PLoS One       Date:  2015-03-13       Impact factor: 3.240

10.  New Insights into Orphan Nuclear Receptor SHP in Liver Cancer.

Authors:  An Zou; Sarah Lehn; Nancy Magee; Yuxia Zhang
Journal:  Nucl Receptor Res       Date:  2015-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.